IDEAS home Printed from https://ideas.repec.org/e/pbo33.html
   My authors  Follow this author

Farasat A.S. Bokhari

Personal Details

First Name:Farasat
Middle Name:A.S.
Last Name:Bokhari
Suffix:
RePEc Short-ID:pbo33
[This author has chosen not to make the email address public]
https://fbokhari.github.io/
Terminal Degree:2001 H. John Heinz III School of Public Policy and Management; Carnegie Mellon University (from RePEc Genealogy)

Affiliation

(50%) Centre for Competition Policy
University of East Anglia

Norwich, United Kingdom
http://www.ccp.uea.ac.uk/
RePEc:edi:ccueauk (more details at EDIRC)

(50%) School of Economics
University of East Anglia

Norwich, United Kingdom
http://www.uea.ac.uk/eco/
RePEc:edi:esueauk (more details at EDIRC)

Research output

as
Jump to: Working papers Articles Chapters

Working papers

  1. Angenendt, David & Bokhari, Farasat & Mariusso, Franco & Zhang, Junjun, 2024. "A Comment on Sampson (2023)," I4R Discussion Paper Series 114, The Institute for Replication (I4R).
  2. Farasat A.S. Bokhari & Paul W. Dobson, 2022. "Banning Volume Discounts to Curb Excessive Consumption: A Cautionary Tale," Working Paper series, University of East Anglia, Centre for Competition Policy (CCP) 2022-04, Centre for Competition Policy, University of East Anglia, Norwich, UK..
  3. Bokhari, Farasat A. S. & Yan, Weijie, 2020. "Product line extensions under the threat of entry: evidence from the UK pharmaceuticals market," Papers WP678, Economic and Social Research Institute (ESRI).
  4. Farasat A.S. Bokhari & Franco Mariuzzo & Arnold Polanski, 2020. "Entry limiting agreements: First mover advantage, authorized generics and pay-for-delay deals," Working Paper series, University of East Anglia, Centre for Competition Policy (CCP) 2015-05v4, Centre for Competition Policy, University of East Anglia, Norwich, UK..
  5. Farasat A.S. Bokhari & Franco Mariuzzo & Weijie Yan, 2019. "Antibacterial resistance and the cost of affecting demand: the case of UK antibiotics," Working Paper series, University of East Anglia, Centre for Competition Policy (CCP) 2019-03, Centre for Competition Policy, University of East Anglia, Norwich, UK..
  6. Farasat A.S. Bokhari & Franco Mariuzzo & Anna Rita Bennato, 2019. "Innovation and growth in the UK pharmaceuticals: the case of product and marketing introductions," Working Paper series, University of East Anglia, Centre for Competition Policy (CCP) 2016-01v3, Centre for Competition Policy, University of East Anglia, Norwich, UK..
  7. Farasat A.S. Bokhari & Franco Mariuzzo, 2018. "Demand estimation and merger simulations for drugs: Logits v. AIDS," Working Paper series, University of East Anglia, Centre for Competition Policy (CCP) 2016-06v3, Centre for Competition Policy, University of East Anglia, Norwich, UK..
  8. Ryota Nakamura & James Lomas & Karl Claxton & Farasat Bokhari & Rodrigo Moreno Serra & Marc Suhrcke, 2016. "Assessing the impact of health care expenditures on mortality using cross-country data," Working Papers 128cherp, Centre for Health Economics, University of York.
  9. Farasat A.S. Bokhari, 2013. "What is the price of pay-to-delay deals?," Working Paper series, University of East Anglia, Centre for Competition Policy (CCP) 2013-01, Centre for Competition Policy, University of East Anglia, Norwich, UK..
  10. Farasat A.S. Bokhari & Gary M. Fournier, 2009. "Entry in the ADHD drugs market: Welfare impact of generics and me-toos," Working Papers wp2009_05_01, Department of Economics, Florida State University.
  11. Farasat A.S. Bokhari & Helen Schnedier, 2009. "School accountability laws and the consumption of psychostimulants," Working Papers wp2009_03_02, Department of Economics, Florida State University, revised 08 Mar 2009.
  12. Farasat A.S. Bokhari & Yunwei Gai & Pablo Gottret, 2005. "Government Health Expenditures and Health Outcomes," Working Papers wp2005_02_01, Department of Economics, Florida State University, revised May 2006.
  13. Farasat A.S. Bokhari & Rick Mayes & Richard M. Scheffler, 2003. "An analysis of the significant variation in psychostimulant use across the U.S," Working Papers wp2003_01_01, Department of Economics, Florida State University, revised Apr 2004.
  14. Farasat A.S. Bokhari, 2001. "Managed Care and the Adoption of Hospital Technology: The Case of Cardiac Catherterization," Working Papers wp2001_10_02, Department of Economics, Florida State University, revised Feb 2006.
  15. Farasat Bokhari & George W. McCarthy, 1996. "Optimum Population -- A New Look: A Hamiltonian Approach Towards A Dynamic Analysis," Labor and Demography 9607002, University Library of Munich, Germany.
  16. Ashish Arora & Farasat Bokhari, 1996. "Returns to Specialization, Transaction Costs, and the Dynamics of Industry Evolution," Industrial Organization 9606002, University Library of Munich, Germany, revised 07 Jul 1998.

Articles

  1. Bokhari, Farasat A.S. & Mariuzzo, Franco & Yan, Weijie, 2024. "Antibacterial resistance and the cost of affecting demand: The case of UK antibiotics," International Journal of Industrial Organization, Elsevier, vol. 95(C).
  2. Ahmad, Husnain F & Banuri, Sheheryar & Bokhari, Farasat, 2024. "Discrimination in healthcare: A field experiment with Pakistan's transgender community," Labour Economics, Elsevier, vol. 87(C).
  3. Farasat A. S. Bokhari & Ratula Chakraborty & Paul W. Dobson & Marcello Morciano, 2024. "Lockdown drinking: The sobering effect of price controls in a pandemic," Economic Inquiry, Western Economic Association International, vol. 62(4), pages 1539-1557, October.
  4. Bokhari, Farasat A.S. & Dobson, Paul W. & Morciano, Marcello & Suhrcke, Marc, 2023. "Banning volume discounts to curb excessive consumption: A cautionary tale," European Economic Review, Elsevier, vol. 156(C).
  5. Farasat A. S. Bokhari & Franco Mariuzzo & Anna Rita Bennato, 2021. "Innovation and growth in the UK pharmaceuticals: the case of product and marketing introductions," Small Business Economics, Springer, vol. 57(1), pages 603-634, June.
  6. Farasat A. S. Bokhari & Franco Mariuzzo & Arnold Polanski, 2020. "Entry limiting agreements: First‐mover advantage, authorized generics, and pay‐for‐delay deals," Journal of Economics & Management Strategy, Wiley Blackwell, vol. 29(3), pages 516-542, July.
  7. Bokhari, Farasat A.S. & Mariuzzo, Franco, 2018. "Demand estimation and merger simulations for drugs: Logits v. AIDS," International Journal of Industrial Organization, Elsevier, vol. 61(C), pages 653-685.
  8. Farasat Bokhari & Ian Wellwood & Anthony Rudd & Peter Langhorne & Martin Dennis & Charles Wolfe, 2014. "Selective admission into stroke unit and patient outcomes: a tale of four cities," Health Economics Review, Springer, vol. 4(1), pages 1-10, December.
  9. Farasat A.S. Bokhari, 2013. "What Is The Price Of Pay-To-Delay Deals?," Journal of Competition Law and Economics, Oxford University Press, vol. 9(3), pages 739-753.
  10. Farasat A. S. Bokhari & Gary M. Fournier, 2013. "Entry in the ADHD drugs market: Welfare impact of generics and me-too's," Journal of Industrial Economics, Wiley Blackwell, vol. 61(2), pages 339-392, June.
  11. Bokhari, Farasat A.S. & Schneider, Helen, 2011. "School accountability laws and the consumption of psychostimulants," Journal of Health Economics, Elsevier, vol. 30(2), pages 355-372, March.
  12. Bokhari, Farasat A.S., 2009. "Managed care competition and the adoption of hospital technology: The case of cardiac catheterization," International Journal of Industrial Organization, Elsevier, vol. 27(2), pages 223-237, March.
  13. Ashish Arora & Farasat A. S. Bokhari, 2007. "Open Versus Closed Firms And The Dynamics Of Industry Evolution," Journal of Industrial Economics, Wiley Blackwell, vol. 55(3), pages 499-527, September.
  14. Farasat A. S. Bokhari & Yunwei Gai & Pablo Gottret, 2007. "Government health expenditures and health outcomes," Health Economics, John Wiley & Sons, Ltd., vol. 16(3), pages 257-273, March.

Chapters

  1. Ryota Nakamura & James Lomas & Karl Claxton & Farasat Bokhari & Rodrigo Moreno-Serra & Marc Suhrcke & Peter Berman, 2020. "Assessing the Impact of Health Care Expenditures on Mortality Using Cross-Country Data," World Scientific Book Chapters, in: Paul Revill & Marc Suhrcke & Rodrigo Moreno-Serra & Mark Sculpher (ed.), Global Health Economics Shaping Health Policy in Low- and Middle-Income Countries, chapter 1, pages 3-49, World Scientific Publishing Co. Pte. Ltd..

Citations

Many of the citations below have been collected in an experimental project, CitEc, where a more detailed citation analysis can be found. These are citations from works listed in RePEc that could be analyzed mechanically. So far, only a minority of all works could be analyzed. See under "Corrections" how you can help improve the citation analysis.

Working papers

  1. Bokhari, Farasat A. S. & Yan, Weijie, 2020. "Product line extensions under the threat of entry: evidence from the UK pharmaceuticals market," Papers WP678, Economic and Social Research Institute (ESRI).

    Cited by:

    1. Hattori, Keisuke & Yamada, Mai, 2020. "Welfare Implications of Sequential Entry with Heterogeneous Firms," MPRA Paper 103422, University Library of Munich, Germany.

  2. Farasat A.S. Bokhari & Franco Mariuzzo & Weijie Yan, 2019. "Antibacterial resistance and the cost of affecting demand: the case of UK antibiotics," Working Paper series, University of East Anglia, Centre for Competition Policy (CCP) 2019-03, Centre for Competition Policy, University of East Anglia, Norwich, UK..

    Cited by:

    1. Dubois, Pierre & Gokkoca, Gokce, 2023. "Antibiotic Demand in the Presence of Antimicrobial Resistance," TSE Working Papers 23-1457, Toulouse School of Economics (TSE).

  3. Farasat A.S. Bokhari & Franco Mariuzzo & Anna Rita Bennato, 2019. "Innovation and growth in the UK pharmaceuticals: the case of product and marketing introductions," Working Paper series, University of East Anglia, Centre for Competition Policy (CCP) 2016-01v3, Centre for Competition Policy, University of East Anglia, Norwich, UK..

    Cited by:

    1. Alex Coad, 2022. "Lumps, Bumps and Jumps in the Firm Growth Process," Foundations and Trends(R) in Entrepreneurship, now publishers, vol. 18(4), pages 212-267, April.

  4. Farasat A.S. Bokhari & Franco Mariuzzo, 2018. "Demand estimation and merger simulations for drugs: Logits v. AIDS," Working Paper series, University of East Anglia, Centre for Competition Policy (CCP) 2016-06v3, Centre for Competition Policy, University of East Anglia, Norwich, UK..

    Cited by:

    1. María T. Verónica Culós & María Florencia Gabrielli & Marcos Herrera Gómez, 2022. "Market power in the Argentine liquid fuels wholesale chain," Asociación Argentina de Economía Política: Working Papers 4554, Asociación Argentina de Economía Política.

  5. Ryota Nakamura & James Lomas & Karl Claxton & Farasat Bokhari & Rodrigo Moreno Serra & Marc Suhrcke, 2016. "Assessing the impact of health care expenditures on mortality using cross-country data," Working Papers 128cherp, Centre for Health Economics, University of York.

    Cited by:

    1. Emanuele Arcà & Francesco Principe & Eddy Van Doorslaer, 2020. "Death by austerity? The impact of cost containment on avoidable mortality in Italy," Health Economics, John Wiley & Sons, Ltd., vol. 29(12), pages 1500-1516, December.
    2. Jessica Ochalek & Haiyin Wang & Yuanyuan Gu & James Lomas & Henry Cutler & Chunlin Jin, 2020. "Informing a Cost-Effectiveness Threshold for Health Technology Assessment in China: A Marginal Productivity Approach," PharmacoEconomics, Springer, vol. 38(12), pages 1319-1331, December.
    3. Jacopo Gabani & Sumit Mazumdar & Marc Suhrcke, 2023. "The effect of health financing systems on health system outcomes: A cross‐country panel analysis," Health Economics, John Wiley & Sons, Ltd., vol. 32(3), pages 574-619, March.

  6. Farasat A.S. Bokhari, 2013. "What is the price of pay-to-delay deals?," Working Paper series, University of East Anglia, Centre for Competition Policy (CCP) 2013-01, Centre for Competition Policy, University of East Anglia, Norwich, UK..

    Cited by:

    1. Eric Helland & Seth A. Seabury, 2016. "Are Settlements in Patent Litigation Collusive? Evidence from Paragraph IV Challenges," NBER Working Papers 22194, National Bureau of Economic Research, Inc.
    2. Montez, João & Marxen, Annabelle, 2020. "Licensing at the patent cliff and market entry," CEPR Discussion Papers 14276, C.E.P.R. Discussion Papers.
    3. Atanu Saha & Yong Xu, 2023. "Estimating Brand Drugs’ Payoff from Pay-for-Delay Deals," Journal of Industry, Competition and Trade, Springer, vol. 23(1), pages 81-99, June.

  7. Farasat A.S. Bokhari & Gary M. Fournier, 2009. "Entry in the ADHD drugs market: Welfare impact of generics and me-toos," Working Papers wp2009_05_01, Department of Economics, Florida State University.

    Cited by:

    1. Arcidiacono, Peter & Ellickson, Paul B. & Landry, Peter & Ridley, David B., 2013. "Pharmaceutical followers," International Journal of Industrial Organization, Elsevier, vol. 31(5), pages 538-553.
    2. Inge Geyskens & Barbara Deleersnyder & Marnik G. Dekimpe & Didi Lin, 2024. "Do consumers benefit from national-brand listings by hard discounters?," Journal of the Academy of Marketing Science, Springer, vol. 52(1), pages 97-118, January.
    3. Kyle, Margaret, 2017. "Are Important Innovations Rewarded? Evidence from Pharmaceutical Markets," CEPR Discussion Papers 12420, C.E.P.R. Discussion Papers.
    4. Lee G. Branstetter & Chirantan Chatterjee & Matthew Higgins, 2011. "Regulation and Welfare: Evidence from Paragraph IV Generic Entry in the Pharmaceutical Industry," NBER Working Papers 17188, National Bureau of Economic Research, Inc.
    5. Sacks, Daniel W., 2018. "Why do HMOs spend less? Patient selection, physician price sensitivity, and prices," Journal of Public Economics, Elsevier, vol. 168(C), pages 146-161.
    6. Farasat A.S. Bokhari & Helen Schnedier, 2009. "School accountability laws and the consumption of psychostimulants," Working Papers wp2009_03_02, Department of Economics, Florida State University, revised 08 Mar 2009.
    7. Duso, T. & Herr, A. & Suppliet, M, 2014. "The Welfare Impact of Parallel Imports: A Structural Approach Applied to the German Market for Oral Anti-diabetics," Health, Econometrics and Data Group (HEDG) Working Papers 14/09, HEDG, c/o Department of Economics, University of York.
    8. Sarmah, Archita & De Giovanni, Domenico & De Giovanni, Pietro, 2020. "Compulsory licenses in the pharmaceutical industry: Pricing and R&D strategies," European Journal of Operational Research, Elsevier, vol. 282(3), pages 1053-1069.
    9. Keaton Miller & Boyoung Seo, 2021. "The Effect of Cannabis Legalization on Substance Demand and Tax Revenues," National Tax Journal, University of Chicago Press, vol. 74(1), pages 107-145.
    10. Lee Branstetter & Chirantan Chatterjee & Matthew J. Higgins, 2014. "Generic Competition and the Incentives for Early-Stage Pharmaceutical Innovation," NBER Working Papers 20532, National Bureau of Economic Research, Inc.
    11. Farasat A.S. Bokhari & Franco Mariuzzo, 2018. "Demand estimation and merger simulations for drugs: Logits v. AIDS," Working Paper series, University of East Anglia, Centre for Competition Policy (CCP) 2016-06v3, Centre for Competition Policy, University of East Anglia, Norwich, UK..
    12. Gugler, Klaus & Szücs, Florian, 2023. "Market Power and Regulation in Pharmaceutical Markets," Department of Economics Working Paper Series 343, WU Vienna University of Economics and Business.
    13. Gilad Sorek, 2015. "Health Insurance and Competition in Health Care Markets," Auburn Economics Working Paper Series auwp2015-03, Department of Economics, Auburn University.
    14. Margaret K. Kyle, 2018. "Are Important Innovations Rewarded? Evidence from Pharmaceutical Markets," Review of Industrial Organization, Springer;The Industrial Organization Society, vol. 53(1), pages 211-234, August.
    15. He, Wentao & Hao, Xiaoli, 2023. "Competition and welfare effects of introducing new products into the new energy vehicle market: Empirical evidence from Tesla’s entry into the Chinese market," Transportation Research Part A: Policy and Practice, Elsevier, vol. 174(C).
    16. Farasat A. S. Bokhari & Franco Mariuzzo & Anna Rita Bennato, 2021. "Innovation and growth in the UK pharmaceuticals: the case of product and marketing introductions," Small Business Economics, Springer, vol. 57(1), pages 603-634, June.
    17. Callejas, Jerónimo & Mohapatra, Debi Prasad, 2021. "Welfare effects of public procurement of medicines: Evidence from Ecuador," International Journal of Industrial Organization, Elsevier, vol. 75(C).

  8. Farasat A.S. Bokhari & Helen Schnedier, 2009. "School accountability laws and the consumption of psychostimulants," Working Papers wp2009_03_02, Department of Economics, Florida State University, revised 08 Mar 2009.

    Cited by:

    1. Marcus, Jan & Reif, Simon & Wuppermann, Amélie & Rouche, Amélie, 2020. "Increased instruction time and stress-related health problems among school children," EconStor Open Access Articles and Book Chapters, ZBW - Leibniz Information Centre for Economics, vol. 70.
    2. Bertoni, Marco & Brunello, Giorgio & Rocco, Lorenzo, 2013. "When the cat is near, the mice won't play: the effect of external examiners in Italian schools," LSE Research Online Documents on Economics 48918, London School of Economics and Political Science, LSE Library.
    3. Simon Burgess, 2022. "Beyond the threshold: The implications for pupil achievement of reforming school performance metrics," Bristol Economics Discussion Papers 22/770, School of Economics, University of Bristol, UK.
    4. Farasat A.S. Bokhari & Franco Mariuzzo, 2018. "Demand estimation and merger simulations for drugs: Logits v. AIDS," Working Paper series, University of East Anglia, Centre for Competition Policy (CCP) 2016-06v3, Centre for Competition Policy, University of East Anglia, Norwich, UK..
    5. Anna Chorniy & Janet Currie & Lyudmyla Sonchak, 2017. "Exploding Asthma and ADHD Caseloads: The Role of Medicaid Managed Care," NBER Working Papers 23983, National Bureau of Economic Research, Inc.
    6. Patricia M. Anderson & Kristin F. Butcher & Diane Whitmore Schanzenbach, 2017. "Adequate (or Adipose?) Yearly Progress: Assessing the Effect of “No Child Left Behind” on Children's Obesity," Education Finance and Policy, MIT Press, vol. 12(1), pages 54-76, Winter.
    7. Farasat A.S. Bokhari & Gary M. Fournier, 2009. "Entry in the ADHD drugs market: Welfare impact of generics and me-toos," Working Papers wp2009_05_01, Department of Economics, Florida State University.
    8. Burgess, Simon & Thomson, Dave, 2023. "Beyond the threshold: The implications for pupil achievement of reforming school performance metrics," Economics of Education Review, Elsevier, vol. 97(C).
    9. Brun, Cédric & Demazeux, Steeves & Vittorio, Pierangelo Di & Gonon, François & Gorry, Philippe & Konsman, Jan Peter & Lung, Fanny & Lung, Yannick & Minard, Michel & Montalban, Matthieu & Rumeau, Nicol, 2015. "La construction des catégories diagnostiques de maladie mentale," Revue de la Régulation - Capitalisme, institutions, pouvoirs, Association Recherche et Régulation, vol. 17.
    10. Hampton, Matt & McNamara, Scott, 2022. "The impact of educational rewards on the diagnosis of autism spectrum disorder," Economics & Human Biology, Elsevier, vol. 47(C).
    11. Owens, Jayanti, 2021. "Parental intervention in school, academic pressure, and childhood diagnoses of ADHD," Social Science & Medicine, Elsevier, vol. 272(C).

  9. Farasat A.S. Bokhari & Yunwei Gai & Pablo Gottret, 2005. "Government Health Expenditures and Health Outcomes," Working Papers wp2005_02_01, Department of Economics, Florida State University, revised May 2006.

    Cited by:

    1. Shinya Kajitani & Shuzo Nishimura & Keisuke Tokunaga, 2009. "Why Do the Japanese Enjoy Longevity? Do Health Care Expenditures Contribute it? (Revised Version of "The Impact of Healthcare Expenditures on Longevity in Japan: Evidence from Longitudinal, Prefe," Discussion Papers 15, Meisei University, School of Economics.
    2. S.N. Yashin & N.I. Yashina & E.V. Poyushcheva & E.S. Malysheva & N.N. Pronchatova-Rubtsova & O.I. Kashina, 2018. "Evaluating the Effectiveness of Public Health Financing Based on Financial and Non-Financial Indicators in Terms of the Knowledge Economy," European Research Studies Journal, European Research Studies Journal, vol. 0(Special 2), pages 112-123.
    3. Kato, Kepha & Mugarura, Alex & Keberuka, Will & Matovu, Fred & Yawe, Bruno L., 2018. "The Effect of Public Health Spending on Under-five Mortality Rate in Uganda," African Journal of Economic Review, African Journal of Economic Review, vol. 6(1), January.
    4. Kossi Atsutsè Dziédzom Tsomdzo & Yacobou Sanoussi & Kodjo Evlo, 2022. "Investissement en santé et état de santé dans les pays de l'UEMOA: entre contribution publique et privée?," African Development Review, African Development Bank, vol. 34(2), pages 244-254, June.
    5. Mudassir Ali & Durdana Qaiser Gilani & An ul Abdin, 2020. "Public Health Care and Government Health Expenditures in Pakistan," Journal of Economic Impact, Science Impact Publishers, vol. 2(3), pages 93-98.
    6. AfDB AfDB, 2007. "Working Paper 91 - Health Expenditures and Health Outcomes in Africa," Working Paper Series 2224, African Development Bank.
    7. Désiré Avom & Gilles Dufrénot & Sylvie Eyeffa, 2023. "Does ICT access and usage reduce growth inefficiency in Sub-Saharan Africa?," Working Papers hal-04017691, HAL.
    8. Craig Arthur Gallet, 2017. "The Impact of Public Health Spending on California STD Rates," International Advances in Economic Research, Springer;International Atlantic Economic Society, vol. 23(2), pages 149-159, May.
    9. Georgios Nikolopoulos & Pantelis Bagos & Theodoros Lytras & Stefanos Bonovas, 2011. "An Ecological Study of the Determinants of Differences in 2009 Pandemic Influenza Mortality Rates between Countries in Europe," PLOS ONE, Public Library of Science, vol. 6(5), pages 1-8, May.
    10. Stephen Hall & Janine Illian & Innocent Makuta & Kyle McNabb & Stuart Murray & Bernadette AM O’Hare & Andre Python & Syed Haider Ali Zaidi & Naor Bar-Zeev, 2021. "Government Revenue and Child and Maternal Mortality," Open Economies Review, Springer, vol. 32(1), pages 213-229, February.
    11. Azza Mohamed Hegazy, 2016. "Mobile Phone and Child Mortality: The Case of Developing Countries," International Journal of Economics and Financial Issues, Econjournals, vol. 6(3), pages 917-925.
    12. Patrick GUILLAUMONT, 2009. "Aid effectiveness for poverty reduction: macroeconomic overview and emerging issues," Working Papers P05, FERDI.
    13. Patrick Guillaumont, 2011. "Aid effectiveness for poverty reduction:macroeconomic overview and emerging issues," CERDI Working papers halshs-00554285, HAL.
    14. Keita, Moussa, 2013. "Standards of living and health status: the socioeconomic determinants of life expectancy gain in sub-Saharan Africa," MPRA Paper 57553, University Library of Munich, Germany.
    15. Oduyemi, Gabriel Olusegun & Owoeye, Taiwo & Adekoya, Oluwasegun Babatunde, 2021. "Health outcomes and the resource curse paradox: The experience of African oil-rich countries," Resources Policy, Elsevier, vol. 73(C).
    16. Mduduzi Biyase & Tajul Ariffin Masron & Talent Zwane & Thomas Bilaliib Udimal & Frederich Kirsten, 2023. "Ecological Footprint and Population Health Outcomes: Evidence from E7 Countries," Sustainability, MDPI, vol. 15(10), pages 1-18, May.
    17. Tulika Tripathi & Nripendra Kishore Mishra, 2014. "Access to Public Health Services: A Disaggregated Analysis of Uttar Pradesh," Margin: The Journal of Applied Economic Research, National Council of Applied Economic Research, vol. 8(3), pages 257-284, August.
    18. Silvia Moler-Zapata & Noémi Kreif & Jessica Ochalek & Andrew J. Mirelman & Mardiati Nadjib & Marc Suhrcke, 2022. "Estimating the Health Effects of Expansions in Health Expenditure in Indonesia: A Dynamic Panel Data Approach," Applied Health Economics and Health Policy, Springer, vol. 20(6), pages 881-891, November.
    19. Awaworyi Churchill, Sefa & Ocloo, Janet Exornam & Siawor-Robertson, Diana, 2015. "Ethnic diversity makes me sick! An examination of ethnic diversity’s effect on health outcomes," EconStor Preprints 123721, ZBW - Leibniz Information Centre for Economics.
    20. Wagstaff, Adam, 2011. "Fungibility and the impact of development assistance: Evidence from Vietnam's health sector," Journal of Development Economics, Elsevier, vol. 94(1), pages 62-73, January.
    21. Noshaba Aziz & Jun He & Tanwne Sarker & Hongguang Sui, 2021. "Exploring the Role of Health Expenditure and Maternal Mortality in South Asian Countries: An Approach towards Shaping Better Health Policy," IJERPH, MDPI, vol. 18(21), pages 1-14, November.
    22. Emanuele Arcà & Francesco Principe & Eddy Van Doorslaer, 2020. "Death by austerity? The impact of cost containment on avoidable mortality in Italy," Health Economics, John Wiley & Sons, Ltd., vol. 29(12), pages 1500-1516, December.
    23. Shinya Kajitani & Shuzo Nishimura & Keisuke Tokunaga, 2009. "The Impact of Healthcare Expenditures on Longevity in Japan: Evidence from Longitudinal, Prefectural-Level Data," Discussion Papers 13, Meisei University, School of Economics, revised 08 Aug 2009.
    24. Santiago Herrera & Gaobo Pang, 2006. "How Efficient is Public Spending in Education?," Revista ESPE - Ensayos Sobre Política Económica, Banco de la República, vol. 24(51), pages 136-201, June.
    25. Marwa Farag & A. Nandakumar & Stanley Wallack & Dominic Hodgkin & Gary Gaumer & Can Erbil, 2013. "Health expenditures, health outcomes and the role of good governance," International Journal of Health Economics and Management, Springer, vol. 13(1), pages 33-52, March.
    26. Alassane DRABO & Christian EBEKE, 2010. "Remittances, Public Health Spending and Foreign Aid in the Access to Health Care Services in Developing Countries," Working Papers 201004, CERDI.
    27. Bienvenido Ortega & Jesús Sanjuán & Antonio Casquero, 2017. "Determinants of efficiency in reducing child mortality in developing countries. The role of inequality and government effectiveness," Health Care Management Science, Springer, vol. 20(4), pages 500-516, December.
    28. Zhang, Man & Brookins, Oscar T. & Huang, Xiaowei, 2022. "The crowding out effect of central versus local government debt: Evidence from China," Pacific-Basin Finance Journal, Elsevier, vol. 72(C).
    29. Victoria Fan and William Savedoff, 2014. "The Health Financing Transition: A Conceptual Framework and Empirical Evidence - Working Paper 358," Working Papers 358, Center for Global Development.
    30. Edney, L.C. & Haji Ali Afzali, H. & Cheng, T.C. & Karnon, J., 2018. "Mortality reductions from marginal increases in public spending on health," Health Policy, Elsevier, vol. 122(8), pages 892-899.
    31. Craig Gallet, 2009. "The Determinants of AIDS Mortality: Evidence from a State-Level Panel," Atlantic Economic Journal, Springer;International Atlantic Economic Society, vol. 37(4), pages 425-436, December.
    32. Dutta, Ujjal Protim & Gupta, Hemant & Sengupta, Partha Pratim, 2019. "ICT and health outcome nexus in 30 selected Asian countries: Fresh evidence from panel data analysis," Technology in Society, Elsevier, vol. 59(C).
    33. Jaison Chireshe & Matthew K. Ocran, 2020. "Health care expenditure and health outcomes in sub‐Saharan African countries," African Development Review, African Development Bank, vol. 32(3), pages 349-361, September.
    34. Mehmet Top & Songul Cinaroglu, 2021. "Cluster analysis of health systems in Europe according to life expectancy at birth," International Journal of Health Planning and Management, Wiley Blackwell, vol. 36(6), pages 2162-2181, November.
    35. Seemab Gillani & Muhammad Nouman Shafiq & Tusawar Iftikhar Ahmad, 2019. "Military Expenditures and Health Outcomes: A Global Perspective," iRASD Journal of Economics, International Research Alliance for Sustainable Development (iRASD), vol. 1(1), pages 1-20, June.
    36. Austin, Kelly F. & DeScisciolo, Cristina & Samuelsen, Lene, 2016. "The Failures of Privatization: A Comparative Investigation of Tuberculosis Rates and the Structure of Healthcare in Less-Developed Nations, 1995–2010," World Development, Elsevier, vol. 78(C), pages 450-460.
    37. Mulcahy, Patrick & Mahal, Ajay & McPake, Barbara & Kane, Sumit & Ghosh, Prabir Kumar & Lee, John Tayu, 2021. "Is there an association between public spending on health and choice of healthcare providers across socioeconomic groups in India? - Evidence from a national sample," Social Science & Medicine, Elsevier, vol. 285(C).
    38. Yusuke Kamiya, 2010. "Determinants of Health in Developing Countries:Cross-Country Evidence," OSIPP Discussion Paper 10E009, Osaka School of International Public Policy, Osaka University.
    39. Sunhee Kim & Jaesun Wang, 2019. "Does Quality of Government Matter in Public Health?: Comparing the Role of Quality and Quantity of Government at the National Level," Sustainability, MDPI, vol. 11(11), pages 1-24, June.
    40. Patrick Guillaumont & Laurent Wagner, 2014. "Aid Effectiveness for Poverty Reduction: Lessons from Cross‑country Analyses, with a Special Focus on Vulnerable Countries," Revue d’économie du développement, De Boeck Université, vol. 22(HS01), pages 217-261.
    41. AfDB AfDB, 2007. "Working Paper 91 - Health Expenditures and Health Outcomes in Africa," Working Paper Series 2304, African Development Bank.
    42. Kaushal, Kaushalendra Kumar & F Ram, Faujdar Ram & Abhishek, Abhishek Singh, 2013. "Public Spending on Health and Childhood Mortality in India," MPRA Paper 48680, University Library of Munich, Germany.
    43. Bindeswar Prasad LEKHAK, 2023. "Health Aid and Human Well-being: Exploring the Role of Donor Support in Developing Countries (Evidence from Fifty Developing Countries’ Dynamic Panel Data Analysis)," Global Journal of Health Science, Canadian Center of Science and Education, vol. 15(10), pages 33-72, October.
    44. Jonas Minet Kinge & Jostein Grytten, 2021. "The impact of primary care physician density on perinatal health: Evidence from a natural experiment," Health Economics, John Wiley & Sons, Ltd., vol. 30(12), pages 2974-2994, December.
    45. Micheal Kofi Boachie & K. Ramu, 2018. "Distribution of the benefits from public health expenditures in Ghana," Quality & Quantity: International Journal of Methodology, Springer, vol. 52(1), pages 415-430, January.
    46. Jeffrey Kouton & Rafiou R. Bétila & Moïse Lawin, 2021. "The Impact of ICT Development on Health Outcomes in Africa: Does Economic Freedom Matter?," Journal of the Knowledge Economy, Springer;Portland International Center for Management of Engineering and Technology (PICMET), vol. 12(4), pages 1830-1869, December.
    47. Jessica Ochalek & Karl Claxton & Paul Revill & Mark Sculpher & Alexandra Rollinger, 2016. "Supporting the development of an essential health package: principles and initial assessment for Malawi," Working Papers 136cherp, Centre for Health Economics, University of York.
    48. Szklo, Michel & Clarke, Damian & Rocha, Rudi, 2024. "Does Increasing Public Spending in Health Improve Health? Lessons from a Constitutional Reform in Brazil," IZA Discussion Papers 16829, Institute of Labor Economics (IZA).
    49. Jessica Ochalek & James Lomas & Karl Claxton, 2015. "Cost per DALY averted thresholds for low- and middle-income countries: evidence from cross country data," Working Papers 122cherp, Centre for Health Economics, University of York.
    50. David M Bishai & Robert Cohen & Y Natalia Alfonso & Taghreed Adam & Shyama Kuruvilla & Julian Schweitzer, 2016. "Factors Contributing to Maternal and Child Mortality Reductions in 146 Low- and Middle-Income Countries between 1990 and 2010," PLOS ONE, Public Library of Science, vol. 11(1), pages 1-13, January.
    51. Désiré Avom & Gilles Dufrénot & Sylvie Eyeffa, 2023. "Does ICT access and usage reduce growth inefficiency in Sub-Saharan Africa?," AMSE Working Papers 2306, Aix-Marseille School of Economics, France.
    52. Sweidan, Osama D. & Alwaked, Ahmed A., 2016. "Economic development and the energy intensity of human well-being: Evidence from the GCC countries," Renewable and Sustainable Energy Reviews, Elsevier, vol. 55(C), pages 1363-1369.
    53. Fiseha Gebregziabher & Miguel Niño-Zarazúa, 2014. "Social Spending and Aggregate Welfare in Developing and Transition Economies," WIDER Working Paper Series wp-2014-082, World Institute for Development Economic Research (UNU-WIDER).
    54. Sefa Awaworyi Churchill & Janet Exornam Ocloo & Diana Siawor-Robertson, 2017. "Ethnic Diversity and Health Outcomes," Social Indicators Research: An International and Interdisciplinary Journal for Quality-of-Life Measurement, Springer, vol. 134(3), pages 1077-1112, December.
    55. Mongbet Zounkifirou & TOURERE Zenabou & Poutouochi Mongapna Arouna, 2021. "Health Spending, Democracy and Child Mortality in Developing Countries," International Journal of Research and Innovation in Social Science, International Journal of Research and Innovation in Social Science (IJRISS), vol. 5(09), pages 654-661, September.
    56. Herrera, Santiago & Pang, Gaobo, 2005. "Efficiency of public spending in developing countries : an efficiency frontier approach," Policy Research Working Paper Series 3645, The World Bank.
    57. Gallet, Craig A. & Doucouliagos, Hristos, 2017. "The impact of healthcare spending on health outcomes: A meta-regression analysis," Social Science & Medicine, Elsevier, vol. 179(C), pages 9-17.
    58. Ujjal Protim Dutta & Hemant Gupta & Asok Kumar Sarkar & Partha Pratim Sengupta, 2020. "Some Determinants of Infant Mortality Rate in SAARC Countries: an Empirical Assessment through Panel Data Analysis," Child Indicators Research, Springer;The International Society of Child Indicators (ISCI), vol. 13(6), pages 2093-2116, December.
    59. Subhalaxmi Mohapatra, 2017. "Health inequity and health outcome: a causal linkage study of low and middle income countries," Quality & Quantity: International Journal of Methodology, Springer, vol. 51(6), pages 2475-2488, November.
    60. Claxton, Karl & Asaria, Miqdad & Chansa, Collins & Jamison, Julian & Lomas, James & Ochalek, Jessica & Paulden, Mike, 2019. "Accounting for Timing when Assessing Health-Related Policies," Journal of Benefit-Cost Analysis, Cambridge University Press, vol. 10(S1), pages 73-105, April.
    61. Enami, Ali, 2016. "Determinants of Child Mortality in Africa: A Methodological Discussion," MPRA Paper 68671, University Library of Munich, Germany.
    62. Hauck, K. & Martin, S. & Smith, P.C., 2016. "Priorities for action on the social determinants of health: Empirical evidence on the strongest associations with life expectancy in 54 low-income countries, 1990–2012," Social Science & Medicine, Elsevier, vol. 167(C), pages 88-98.
    63. Fan, Victoria Y. & Savedoff, William D., 2014. "The health financing transition: A conceptual framework and empirical evidence," Social Science & Medicine, Elsevier, vol. 105(C), pages 112-121.
    64. Brosio, Giorgio & Zanola, Roberto, 2008. "The welfare costs of national standards: a contribution to the debate on the outcomes of de/centralization," POLIS Working Papers 113, Institute of Public Policy and Public Choice - POLIS.
    65. Micheal Kofi Boachie & K. Ramu & Tatjana Põlajeva, 2018. "Public Health Expenditures and Health Outcomes: New Evidence from Ghana," Economies, MDPI, vol. 6(4), pages 1-25, October.
    66. Tayyebe Azodi & Seyed Mohammad Javad Razmi & Ali Akbar Naji Meidani & Mohammad Ali Falahi, 2019. "The Effect of Public and Private Health Expenditures on Life Expectancy in Different Countries: Using Panel Data Model," International Journal of Business and Economic Sciences Applied Research (IJBESAR), International Hellenic University (IHU), Kavala Campus, Greece (formerly Eastern Macedonia and Thrace Institute of Technology - EMaTTech), vol. 12(1), pages 64-69, April.
    67. Jean-Paul Moatti & Bruno Ventelou, 2009. "Économie de la santé dans les pays en développement des paradigmes en mutation," Revue économique, Presses de Sciences-Po, vol. 60(2), pages 241-256.
    68. Hilaire Gbodja Houeninvo, 2022. "Effects of health expenditures on infant and child mortality rates: A dynamic panel data analysis of 37 African countries," African Development Review, African Development Bank, vol. 34(2), pages 255-267, June.
    69. M. M. Goel, Ishu Garg, 2016. "Public Expenditure On Health And Its Impact On Health Infrastructure And Health Status In Haryana," Working papers 2016-09-04, Voice of Research.
    70. Beth Woods & Paul Revill & Mark Sculpher & Karl Claxton, 2015. "Country-level cost-effectiveness thresholds: initial estimates and the need for further research," Working Papers 109cherp, Centre for Health Economics, University of York.
    71. Bernadette O'Hare & Steve G. Hall, 2022. "The Impact of Government Revenue on the Achievement of the Sustainable Development Goals and the Amplification Potential of Good Governance," Central European Journal of Economic Modelling and Econometrics, Central European Journal of Economic Modelling and Econometrics, vol. 14(2), pages 109-129, June.
    72. Dhiman Das, 2017. "Public expenditure and healthcare utilization: the case of reproductive health care in India," International Journal of Health Economics and Management, Springer, vol. 17(4), pages 473-494, December.
    73. João Paulo Magalhães & Joana Pestana & Renato Lourenço Silva & António Pereira & André Biscaia, 2024. "Avoidable hospital admissions depend on the primary healthcare governance model? A global health perspective from Europe countries," American Journal of Economics and Sociology, Wiley Blackwell, vol. 83(1), pages 127-141, January.
    74. Dhrifi, Abdelhafidh, 2018. "Health-care expenditures, economic growth and infant mortality: evidence from developed and developing countries," Revista CEPAL, Naciones Unidas Comisión Económica para América Latina y el Caribe (CEPAL), August.
    75. Mamoon, Dawood & Arshed, Noman & Raza, Sidra, 2015. "Investments in Health and Education Help Save Lives," MPRA Paper 82495, University Library of Munich, Germany.
    76. Viera Ivanková & Rastislav Kotulič & Jaroslav Gonos & Martin Rigelský, 2019. "Health Care Financing Systems and Their Effectiveness: An Empirical Study of OECD Countries," IJERPH, MDPI, vol. 16(20), pages 1-22, October.
    77. Dierk Herzer, 2022. "The macro‐level effect of religiosity on health," Health Economics, John Wiley & Sons, Ltd., vol. 31(6), pages 993-1011, June.
    78. Jessica Ochalek & Miqdad Asaria & Pei Fen Chuar & James Lomas & Sumit Mazumdar & Karl Claxton, 2019. "Assessing health opportunity costs for the Indian health care systems," Working Papers 161cherp, Centre for Health Economics, University of York.
    79. Lucian MIRESCU & Ana-Maria Camelia POPESCU, 2023. "A Statistical Study On Key Performance Indicators In Health System," Management and Marketing Journal, University of Craiova, Faculty of Economics and Business Administration, vol. 0(1), pages 25-35, May.
    80. Boachie, Micheal Kofi & Ramu, K., 2015. "Public Health Expenditure and Health Status in Ghana," MPRA Paper 66371, University Library of Munich, Germany.
    81. Davide Golinelli & Fabrizio Toscano & Andrea Bucci & Jacopo Lenzi & Maria Pia Fantini & Nicola Nante & Gabriele Messina, 2017. "Health Expenditure and All-Cause Mortality in the ‘Galaxy’ of Italian Regional Healthcare Systems: A 15-Year Panel Data Analysis," Applied Health Economics and Health Policy, Springer, vol. 15(6), pages 773-783, December.
    82. Michele Capriati, 2011. "Public Expenditure and Human Development in the Italian Regions," QA - Rivista dell'Associazione Rossi-Doria, Associazione Rossi Doria, issue 2, June.
    83. Marwa Farag & A. NandaKumar & Stanley Wallack & Dominic Hodgkin & Gary Gaumer & Can Erbil, 2012. "The income elasticity of health care spending in developing and developed countries," International Journal of Health Economics and Management, Springer, vol. 12(2), pages 145-162, June.
    84. Akinlo, Anthony E. & Sulola, Abiola O., 2019. "Health care expenditure and infant mortality in sub-Saharan Africa," Journal of Policy Modeling, Elsevier, vol. 41(1), pages 168-178.
    85. ATAKE, Esso - Hanam, 2014. "Financement Public des dépenses de santé et survie infantile au Togo [Public funding of health expenditure and infant survival in Togo]," MPRA Paper 59320, University Library of Munich, Germany, revised 26 Oct 2014.
    86. Omar Galárraga & Veronika J Wirtz & Yared Santa-Ana-Tellez & Eline L Korenromp, 2013. "Financing HIV Programming: How Much Should Low- And Middle-Income Countries and their Donors Pay?," PLOS ONE, Public Library of Science, vol. 8(7), pages 1-11, July.
    87. Callejas, Jerónimo & Mohapatra, Debi Prasad, 2021. "Welfare effects of public procurement of medicines: Evidence from Ecuador," International Journal of Industrial Organization, Elsevier, vol. 75(C).
    88. Subhalaxmi Mohapatra, 2022. "Health Expenditures, Health Infrastructure and Health Status in SAARC Countries: A Panel Data Analysis," Vikalpa: The Journal for Decision Makers, , vol. 47(3), pages 205-216, September.
    89. Jacopo Gabani & Sumit Mazumdar & Marc Suhrcke, 2023. "The effect of health financing systems on health system outcomes: A cross‐country panel analysis," Health Economics, John Wiley & Sons, Ltd., vol. 32(3), pages 574-619, March.
    90. Micheal Kofi Boachie & Tatjana Põlajeva & Albert Opoku Frimpong, 2020. "Infant Mortality in Low- and Middle-income Countries: Does Government Health Spending Matter?," Journal of Development Policy and Practice, , vol. 5(1), pages 54-73, January.
    91. Durdana Qaiser Gillani & Syed Ahmad Saad Gillani & Muhammad Zahid Naeem & Cristi Spulbar & Elizabeth Coker-Farrell & Abdullah Ejaz & Ramona Birau, 2021. "The Nexus between Sustainable Economic Development and Government Health Expenditure in Asian Countries Based on Ecological Footprint Consumption," Sustainability, MDPI, vol. 13(12), pages 1-15, June.
    92. ATAKE, Esso - Hanam, 2014. "Financement Public des dépenses de santé et survie infantile au Togo [Public funding of health expenditure and infant survival in Togo]," MPRA Paper 59516, University Library of Munich, Germany, revised 23 Oct 2014.

  10. Farasat A.S. Bokhari, 2001. "Managed Care and the Adoption of Hospital Technology: The Case of Cardiac Catherterization," Working Papers wp2001_10_02, Department of Economics, Florida State University, revised Feb 2006.

    Cited by:

    1. Rosella Levaggi & Moretto Michele, 2008. "Investment In Hospital Care Technology Under Different Purchasing Rules: A Real Option Approach," Bulletin of Economic Research, Wiley Blackwell, vol. 60(2), pages 159-181, April.
    2. Farasat A.S. Bokhari & Weijie Yan, 2020. "Product line extensions under the threat of entry: evidence from the UK pharmaceuticals market," Working Paper series, University of East Anglia, Centre for Competition Policy (CCP) 2020-04, Centre for Competition Policy, University of East Anglia, Norwich, UK..
    3. Rosella Levaggi & Michele Moretto & Vincenzo Rebba, 2009. "Investment decisions in hospital technology when physicians are devoted workers," Economics of Innovation and New Technology, Taylor & Francis Journals, vol. 18(5), pages 487-512.

  11. Ashish Arora & Farasat Bokhari, 1996. "Returns to Specialization, Transaction Costs, and the Dynamics of Industry Evolution," Industrial Organization 9606002, University Library of Munich, Germany, revised 07 Jul 1998.

    Cited by:

    1. Suma Athreye, 1997. "On Markets in Knowledge," Journal of Management & Governance, Springer;Accademia Italiana di Economia Aziendale (AIDEA), vol. 1(2), pages 231-253, June.

Articles

  1. Farasat A. S. Bokhari & Franco Mariuzzo & Anna Rita Bennato, 2021. "Innovation and growth in the UK pharmaceuticals: the case of product and marketing introductions," Small Business Economics, Springer, vol. 57(1), pages 603-634, June.
    See citations under working paper version above.
  2. Bokhari, Farasat A.S. & Mariuzzo, Franco, 2018. "Demand estimation and merger simulations for drugs: Logits v. AIDS," International Journal of Industrial Organization, Elsevier, vol. 61(C), pages 653-685.
    See citations under working paper version above.
  3. Farasat A.S. Bokhari, 2013. "What Is The Price Of Pay-To-Delay Deals?," Journal of Competition Law and Economics, Oxford University Press, vol. 9(3), pages 739-753.
    See citations under working paper version above.
  4. Farasat A. S. Bokhari & Gary M. Fournier, 2013. "Entry in the ADHD drugs market: Welfare impact of generics and me-too's," Journal of Industrial Economics, Wiley Blackwell, vol. 61(2), pages 339-392, June.
    See citations under working paper version above.
  5. Bokhari, Farasat A.S. & Schneider, Helen, 2011. "School accountability laws and the consumption of psychostimulants," Journal of Health Economics, Elsevier, vol. 30(2), pages 355-372, March.
    See citations under working paper version above.
  6. Bokhari, Farasat A.S., 2009. "Managed care competition and the adoption of hospital technology: The case of cardiac catheterization," International Journal of Industrial Organization, Elsevier, vol. 27(2), pages 223-237, March.

    Cited by:

    1. Jerome Dugan, 2015. "Trends in Managed Care Cost Containment: An Analysis of the Managed Care Backlash," Health Economics, John Wiley & Sons, Ltd., vol. 24(12), pages 1604-1618, December.
    2. Bisceglia, Michele & Cellini, Roberto & Grilli, Luca, 2017. "Regional regulators in healthcare service under quality competition: A game theoretical model," MPRA Paper 80507, University Library of Munich, Germany.
    3. Frankovic, Ivan & Kuhn, Michael & Wrzaczek, Stefan, 2020. "Medical innovation and its diffusion: Implications for economic performance and welfare," Journal of Macroeconomics, Elsevier, vol. 66(C).
    4. Barros Pedro Pita & Martinez-Giralt Xavier, 2015. "Technological Adoption in Health Care – The Role of Payment Systems," The B.E. Journal of Economic Analysis & Policy, De Gruyter, vol. 15(2), pages 709-745, April.
    5. Farasat A.S. Bokhari & Weijie Yan, 2020. "Product line extensions under the threat of entry: evidence from the UK pharmaceuticals market," Working Paper series, University of East Anglia, Centre for Competition Policy (CCP) 2020-04, Centre for Competition Policy, University of East Anglia, Norwich, UK..
    6. Rosella Levaggi & Michele Moretto & Paolo Pertile, 2010. "Static and Dynamic Efficiency of Irreversible Health Care Investments under Alternative Payment Rules," Working Papers 2010.130, Fondazione Eni Enrico Mattei.
    7. Laurence C. Baker & Karine Lamiraud, 2022. "Adoption of hospital diagnosis‐related group financing in Switzerland and the availability of computed tomography scanners," Health Economics, John Wiley & Sons, Ltd., vol. 31(12), pages 2537-2557, December.
    8. Pedro Pita Barros & Xavier Martínez-Giralt, 2009. "Technological adoption in health care," Working Papers 413, Barcelona School of Economics.
    9. Weech-Maldonado, Robert & Elliott, Marc N. & Pradhan, Rohit & Schiller, Cameron & Dreachslin, Janice & Hays, Ron D., 2012. "Moving towards culturally competent health systems: Organizational and market factors," Social Science & Medicine, Elsevier, vol. 75(5), pages 815-822.
    10. Finocchiaro Castro, Massimo & Guccio, Calogero & Pignataro, Giacomo & Rizzo, Ilde, 2014. "The effects of reimbursement mechanisms on medical technology diffusion in the hospital sector in the Italian NHS," Health Policy, Elsevier, vol. 115(2), pages 215-229.
    11. Xidong Guo, 2024. "An analysis of a rural hospital's investment decision under different payment systems," Health Economics, John Wiley & Sons, Ltd., vol. 33(4), pages 714-747, April.

  7. Ashish Arora & Farasat A. S. Bokhari, 2007. "Open Versus Closed Firms And The Dynamics Of Industry Evolution," Journal of Industrial Economics, Wiley Blackwell, vol. 55(3), pages 499-527, September.

    Cited by:

    1. Éric Darmon & Dominique Torre, 2014. "Open Source, Dual Licensing and Software Competition," Economics Working Paper Archive (University of Rennes & University of Caen) 201405, Center for Research in Economics and Management (CREM), University of Rennes, University of Caen and CNRS.
    2. Netsanet Haile & Jörn Altmann, 2017. "Evaluating Investments in Portability and Interoperability between Software Service Platforms," TEMEP Discussion Papers 2017136, Seoul National University; Technology Management, Economics, and Policy Program (TEMEP), revised May 2017.
    3. Kevin Boudreau, 2010. "Open Platform Strategies and Innovation: Granting Access vs. Devolving Control," Management Science, INFORMS, vol. 56(10), pages 1849-1872, October.
    4. Selam Abrham Gebregiorgis & Jorn Altmann, 2012. "IT Service Platforms: Their Value Creation Model and the Impact of their Level of Openness on their Adoption," TEMEP Discussion Papers 201295, Seoul National University; Technology Management, Economics, and Policy Program (TEMEP), revised Jun 2012.
    5. Gastón Llanes & Ramiro de Elejalde, 2009. "Industry Equilibrium with Open Source and Proprietary Firms," Harvard Business School Working Papers 09-149, Harvard Business School.
    6. Yu Wang & Yu Chen & Bonwoo Koo, 2017. "Open Source and Competition Strategy Under Network Effects," Graz Economics Papers 2017-03, University of Graz, Department of Economics.
    7. Greenstein, Shane, 2010. "Innovative Conduct in Computing and Internet Markets," Handbook of the Economics of Innovation, in: Bronwyn H. Hall & Nathan Rosenberg (ed.), Handbook of the Economics of Innovation, edition 1, volume 1, chapter 0, pages 477-537, Elsevier.
    8. Bottai, Carlo, 2015. "Open Innovation in a Model à la Hotelling," Department of Economics and Statistics Cognetti de Martiis. Working Papers 201526, University of Turin.
    9. Constance E. Helfat & Miguel A. Campo-Rembado, 2016. "Integrative Capabilities, Vertical Integration, and Innovation Over Successive Technology Lifecycles," Organization Science, INFORMS, vol. 27(2), pages 249-264, April.

  8. Farasat A. S. Bokhari & Yunwei Gai & Pablo Gottret, 2007. "Government health expenditures and health outcomes," Health Economics, John Wiley & Sons, Ltd., vol. 16(3), pages 257-273, March.
    See citations under working paper version above.

Chapters

  1. Ryota Nakamura & James Lomas & Karl Claxton & Farasat Bokhari & Rodrigo Moreno-Serra & Marc Suhrcke & Peter Berman, 2020. "Assessing the Impact of Health Care Expenditures on Mortality Using Cross-Country Data," World Scientific Book Chapters, in: Paul Revill & Marc Suhrcke & Rodrigo Moreno-Serra & Mark Sculpher (ed.), Global Health Economics Shaping Health Policy in Low- and Middle-Income Countries, chapter 1, pages 3-49, World Scientific Publishing Co. Pte. Ltd..
    See citations under working paper version above.Sorry, no citations of chapters recorded.

More information

Research fields, statistics, top rankings, if available.

Statistics

Access and download statistics for all items

Co-authorship network on CollEc

NEP Fields

NEP is an announcement service for new working papers, with a weekly report in each of many fields. This author has had 12 papers announced in NEP. These are the fields, ordered by number of announcements, along with their dates. If the author is listed in the directory of specialists for this field, a link is also provided.
  1. NEP-COM: Industrial Competition (6) 2009-05-23 2020-08-24 2020-08-24 2020-09-07 2021-01-25 2022-08-22. Author is listed
  2. NEP-HEA: Health Economics (5) 2001-10-09 2006-09-11 2009-05-23 2016-04-16 2020-08-24. Author is listed
  3. NEP-BEC: Business Economics (2) 2020-08-24 2020-09-07
  4. NEP-REG: Regulation (2) 2020-08-24 2022-08-22
  5. NEP-EDU: Education (1) 2009-06-03
  6. NEP-ENE: Energy Economics (1) 2020-08-24
  7. NEP-ENT: Entrepreneurship (1) 2020-08-24
  8. NEP-ENV: Environmental Economics (1) 1998-10-02
  9. NEP-LAW: Law and Economics (1) 2020-09-07
  10. NEP-MKT: Marketing (1) 2009-05-23
  11. NEP-ORE: Operations Research (1) 2020-08-24
  12. NEP-PBE: Public Economics (1) 2006-09-11
  13. NEP-SBM: Small Business Management (1) 2020-08-24
  14. NEP-TID: Technology and Industrial Dynamics (1) 2020-08-24

Corrections

All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. For general information on how to correct material on RePEc, see these instructions.

To update listings or check citations waiting for approval, Farasat A.S. Bokhari should log into the RePEc Author Service.

To make corrections to the bibliographic information of a particular item, find the technical contact on the abstract page of that item. There, details are also given on how to add or correct references and citations.

To link different versions of the same work, where versions have a different title, use this form. Note that if the versions have a very similar title and are in the author's profile, the links will usually be created automatically.

Please note that most corrections can take a couple of weeks to filter through the various RePEc services.

IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.